Meeting
2020 Genitourinary Cancers Symposium
Multiple primary prostate tumors with differential drug sensitivity.
Authors
Scott C. Wilkinson
National Cancer Institute, Bethesda, MD
Scott C. Wilkinson , Huihui Ye , Nicholas Terrigino , Nicole Carrabba , Rayann Atway , Shana Y. Trostel , John Bright , S. Thomas Hennigan , Rosina Lis , Ross Lake , Stephanie Harmon , Baris Turkbey , Peter A. Pinto , Peter L. Choyke , Fatima Karzai , David James VanderWeele , Kathleen Kelly , William L. Dahut , Adam G. Sowalsky
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Translational Research
Clinical Trial Registration Number
NCT02430480
Citation
J Clin Oncol 38, 2020 (suppl 6; abstr 342)
Abstract #
342
Poster Bd #
N4
Abstract Disclosures
Similar Posters
Poster
2020 Genitourinary Cancers Symposium
A tale of lineage plasticity: Intense neoadjuvant testosterone lowering therapy in localized prostate cancer (PCa) harboring high-risk genomic signatures.
First Author: Fatima Karzai
Poster
2018 ASCO Annual Meeting
Neoadjuvant androgen deprivation therapy and enzalutamide: Imaging and pathological responses.
First Author: David James VanderWeele
Poster
2019 Genitourinary Cancers Symposium
A study of intense neoadjuvant testosterone lowering therapy with goserelin and enzalutamide (Enza) in high-risk prostate cancer (PC) with multiparametric MRI (mpMRI).
First Author: Fatima Karzai
Poster
2024 ASCO Genitourinary Cancers Symposium
Weight variation during androgen deprivation therapy in patients with localized prostate cancer: Data from two prospective randomized trials.
First Author: Abdenour Nabid